Company
Headquarters: Toronto, ON, Canada
CEO: Mr. Graham Simmonds
C$3.8 Million
CAD as of Jan. 1, 2024
US$2.9 Million
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada.
Top 1-year algo backtest: +181.22%
$10,000 in June 2023 would now be $28,122 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Aion Therapeutic, Inc. has the following listings and related stock indices.
Stock: CSE: AION wb_incandescent